Life insurers need actionable responses to current underwriting challenges – including the need for fluidless Accelerated Underwriting alternatives, while striving to maintain the same level of mortality.

Gen Re worked with ExamOne to study the value of LabPiQture as a new underwriting tool and recommends using it:

• In underwriting during COVID-19 when traditional requirements may not be available
• As an enhancement to existing AU programs to offset some mortality slippage associated with such programs, as well as to improve time service for a larger segment of business
• As a tool in companies’ full underwriting requirements

The attached white paper provides some insight into our study results.